Sertraline Dosing
For most adult patients with depression or OCD, start sertraline at 50 mg once daily, which serves as both the initial and typically effective therapeutic dose. 1
Adult Dosing by Indication
Major Depressive Disorder and Obsessive-Compulsive Disorder
- Starting dose: 50 mg once daily 1
- This initial dose is the usually effective therapeutic dose for most patients 2
- May be administered at any time of day (morning or evening) 1
Panic Disorder, PTSD, and Social Anxiety Disorder
- Starting dose: 25 mg once daily for the first week 1
- Increase to 50 mg once daily after one week 1
- This lower initial dose helps minimize early side effects in these anxiety-related conditions 1
Premenstrual Dysphoric Disorder (PMDD)
- Starting dose: 50 mg/day 1
- Can be dosed either daily throughout the menstrual cycle or limited to the luteal phase 1
- For luteal phase dosing, use a 50 mg/day titration step for three days at the beginning of each dosing period if escalating to 100 mg/day 1
Dose Escalation Strategy
If patients do not respond adequately to 50 mg/day within 2-4 weeks, increase the dose in 50 mg increments 3, 1
- Maximum dose: 200 mg/day 3, 1
- Minimum interval between dose changes: 1 week (due to sertraline's 24-hour elimination half-life) 1
- Dose increases should occur at no less than weekly intervals 1
- For PMDD with luteal phase dosing, maximum is 100 mg/day; for continuous dosing, maximum is 150 mg/day 1
Pediatric Dosing (Ages 6-17, OCD Only)
Children ages 6-12 years:
- Starting dose: 25 mg once daily 3, 1
- Consider lower body weights when advancing dose to avoid excess dosing 1
Adolescents ages 13-17 years:
For both age groups:
- Maximum dose: 200 mg/day 1
- Increase dose at intervals of at least 1 week 1
- May be given morning or evening 1
Special Populations
Elderly Patients (≥60 years)
- No dosage adjustment needed based on age alone 1, 2
- Use the same starting dose of 50 mg/day as in younger adults 2
- Sertraline is well tolerated in elderly patients with a favorable side effect profile compared to tricyclic antidepressants 4
- The pharmacokinetics in elderly patients are similar to younger adults, eliminating the need for dose reduction 2
Renal Impairment
- No specific dosage adjustment mentioned in FDA labeling 1
Hepatic Impairment
- Use with caution; consider lower or less frequent dosing (though specific recommendations not provided in the evidence) 1
Maintenance Treatment Duration
Major Depressive Disorder:
- Continue treatment for several months or longer beyond initial response 1
- Efficacy demonstrated for up to 44 weeks following 8 weeks of initial treatment 1
PTSD:
- Requires several months or longer of sustained therapy 1
- Efficacy maintained for up to 28 weeks following 24 weeks of treatment 1
Social Anxiety Disorder:
- Chronic condition requiring several months or longer of therapy 1
- Efficacy maintained for up to 24 weeks following 20 weeks of treatment 1
OCD and Panic Disorder:
- Require several months or longer of sustained therapy beyond initial response 1
Discontinuation
Taper sertraline slowly when discontinuing to avoid withdrawal effects 3
- Abrupt discontinuation should be avoided 3
- Gradual dose reduction is recommended, though specific tapering schedules are not provided in the evidence 3
Key Clinical Pearls
- Monitor closely for clinical worsening, suicidality, and unusual behavior changes during the initial months of treatment or at times of dose changes 3
- Sertraline has minimal effects on cytochrome P450 enzymes, resulting in low potential for drug interactions compared to other SSRIs 3, 5
- Steady-state plasma concentrations are reached after approximately 7 days of once-daily dosing 6
- The 50 mg starting dose represents the optimal balance of efficacy and tolerability for most patients 2